The Patent Finder

Terms ending in 2038

BioAtla Inc.

Every in-force patent on BioAtla Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,773,509Conditionally Active Polypeptides and Methods of Generating Them
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 11,293,929Proteins Targeting Orthologs
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 11,584,927Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
In force
 · Low confidence
BioAtla, Inc.In forceLow confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited